SCHEMBL2014257

SCHEMBL2014257

O=CCc1ccc2cccnc2c1-c1ccccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
LMNA P02545 3/20 0.42
MAPT P10636 2/20 0.42
ALOX15 P16050 2/20 0.42
TSHR P16473 2/20 0.42
HTT P42858 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
GMNN O75496 1/20 0.42
TP53 P04637 1/20 0.42
HSP90AA1 P07900 1/20 0.42
MMP2 P08253 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
MMP9 P14780 1/20 0.42
NFKB1 P19838 1/20 0.42
MMP8 P22894 1/20 0.42
CCR1 P32246 1/20 0.42
THPO P40225 1/20 0.42
MTOR P42345 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016907 0.81 KDM4E (0.44) KDM4ELMNAMAPTALOX15TSHR
SCHEMBL2010932 0.80 KDM4E (0.43) KDM4ELMNAMAPTALOX15TSHR
SCHEMBL2016022 0.79 CCR1 (0.39) KDM4ELMNAMAPTALOX15TSHR
SCHEMBL2017973 0.78 L3MBTL1 (0.43) KDM4ELMNAMAPTALOX15HTT
SCHEMBL3904765 0.75 DPP4 (0.42) KDM4ELMNATDP1NPC1MEN1
SCHEMBL2014256 0.72 ALDH1A1 (0.44) KDM4ELMNAMAPTALOX15TSHR
SCHEMBL6225626 0.72 KDM4E (0.48) KDM4ELMNAMAPTALOX15TSHR
SCHEMBL1812109 0.69 KDM1A (0.40) KDM4ETDP1ALDH1A1NPC1MEN1
SCHEMBL29796409 0.69 KDM1A (0.40) KDM4ETDP1ALDH1A1NPC1MEN1
SCHEMBL2010930 0.69 TP53 (0.44) KDM4ELMNAMAPTALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed